These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30009380)
1. Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis. Li F; Yuan W; Wu X Ann Hum Genet; 2018 Nov; 82(6):358-369. PubMed ID: 30009380 [TBL] [Abstract][Full Text] [Related]
2. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort. Cai GM; Gao Z; Yue YX; Xie YC; Gao X; Hao HJ; Zhang XJ; Wang Q; Liang B; Li HF J Clin Neurosci; 2019 Nov; 69():31-37. PubMed ID: 31473094 [TBL] [Abstract][Full Text] [Related]
3. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population. Sun L; Meng Y; Xie Y; Zhang H; Zhang Z; Wang X; Jiang B; Li W; Li Y; Yang Z PLoS One; 2014; 9(7):e101986. PubMed ID: 25003519 [TBL] [Abstract][Full Text] [Related]
4. Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis. Li HF; Hong Y; Zhang X; Xie Y; Skeie GO; Hao HJ; Gilhus NE; Liang B; Yue YX; Zhang XJ; Gao X; Wang Q; Gao Z; Ding XJ; Song M Mol Neurobiol; 2017 Aug; 54(6):4771-4780. PubMed ID: 27501803 [TBL] [Abstract][Full Text] [Related]
5. CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies. Li J; Wang W; Sun Y; Zhu Y World J Surg Oncol; 2020 Mar; 18(1):55. PubMed ID: 32178688 [TBL] [Abstract][Full Text] [Related]
6. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies. Fang M; Huang W; Mo D; Zhao W; Huang R Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese. Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J Front Immunol; 2021; 12():607966. PubMed ID: 33717091 [TBL] [Abstract][Full Text] [Related]
8. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens. Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740 [TBL] [Abstract][Full Text] [Related]
9. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis. Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071 [TBL] [Abstract][Full Text] [Related]
10. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis. Zhao JJ; Wang D; Yao H; Sun DW; Li HY World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408 [TBL] [Abstract][Full Text] [Related]
11. Association of four CTLA-4 gene polymorphisms with pemphigus risk: a systematic review, meta-analysis, and meta-regression. Dhaouadi T; Riahi A; Ben Abdallah T; Gorgi Y; Sfar I J Int Med Res; 2024 Oct; 52(10):3000605241282116. PubMed ID: 39397428 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation. Misra MK; Pandey SK; Kapoor R; Sharma RK; Agrawal S Pharmacogenet Genomics; 2015 Jan; 25(1):19-29. PubMed ID: 25356901 [TBL] [Abstract][Full Text] [Related]
13. A genome-wide association study of myasthenia gravis. Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325 [TBL] [Abstract][Full Text] [Related]
14. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome. Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821 [TBL] [Abstract][Full Text] [Related]
15. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients. Guo Y; Gao J; Gao S; Shang M; Guo F Oncotarget; 2016 Apr; 7(17):23088-95. PubMed ID: 27081086 [TBL] [Abstract][Full Text] [Related]
16. -1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): a comprehensive meta-analysis. Liu J; Zhang H Hum Immunol; 2013 Mar; 74(3):341-7. PubMed ID: 23261408 [TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) and clinical outcomes post-allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Najafi A; Alizadeh-Navaei R; Rahimi S; Valadan R; Tehrani M Clin Transplant; 2021 Aug; 35(8):e14364. PubMed ID: 34008865 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409 [TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of the Genetic Association between PTPN22 and CTLA-4 Variants and Risk of Uveitis. Zhang J; Zhou P; Hu S; Qi J Ophthalmic Res; 2022; 65(3):264-275. PubMed ID: 35130554 [TBL] [Abstract][Full Text] [Related]
20. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm. Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]